Janney Montgomery Scott LLC Raises Position in Addus HomeCare Co. (NASDAQ:ADUS)

Janney Montgomery Scott LLC lifted its position in Addus HomeCare Co. (NASDAQ:ADUS) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,600 shares of the company’s stock after acquiring an additional 234 shares during the quarter. Janney Montgomery Scott LLC owned 0.06% of Addus HomeCare worth $1,410,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its stake in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after buying an additional 88 shares during the last quarter. Quest Partners LLC bought a new position in Addus HomeCare in the 2nd quarter valued at $31,000. EntryPoint Capital LLC purchased a new stake in Addus HomeCare in the first quarter worth $44,000. Innealta Capital LLC bought a new stake in shares of Addus HomeCare during the second quarter worth $44,000. Finally, Farther Finance Advisors LLC lifted its position in shares of Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently commented on ADUS. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday. KeyCorp initiated coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Stephens raised their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Finally, Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Performance

Shares of Addus HomeCare stock opened at $122.07 on Friday. The company has a market capitalization of $2.21 billion, a PE ratio of 27.93, a P/E/G ratio of 2.20 and a beta of 1.04. The company has a 50-day simple moving average of $129.12 and a two-hundred day simple moving average of $122.06. Addus HomeCare Co. has a one year low of $85.43 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.03 EPS. On average, equities analysts predict that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the transaction, the director now owns 3,866 shares in the company, valued at $502,695.98. This represents a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 75.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.